Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Highlights cAMP microdomain alterations in hypertrophy and HF; leaves open targeted interventions pending validation.
3',5'-cyclic adenosine monophosphate (cAMP) is an important second messenger which regulates heart function by acting in distinct subcellular microdomains. Recent years have provided deeper mechanistic insights into compartmentalized cAMP signaling and its link to cardiac disease. In this mini review, we summarize newest developments in this field achieved by cutting-edge biochemical and biophysical techniques. We further compile the data from different studies into a bigger picture of so far uncovered alterations in cardiomyocyte cAMP microdomains which occur in compensated cardiac hypertrophy and chronic heart failure. Finally, future research directions and translational perspectives are briefly discussed.
No takes yet. Share an insight, caveat, or question.
Froese et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: